The Newsletter team is composed of extraordinary individuals with various backgrounds, including basic and clinical scientists. From time to time, we introduce some new members to the team and some of the old members end their term in the Newsletter. This way, ECTS both ensures stability/continuity of the Newsletter and promotes dynamics needed to further improve the Newsletter with fresh enthusiasm.
Hereby, on behalf of the entire Newsletter team, I would like to say a big thank you to Cristiana Cipriani from Sapienza University of Rome for her devoted work in the Newsletter during the past four years! Cristiana was indeed a reliable team member all these years and has contributed substantially to the continuous development of the Newsletter. I particularly enjoyed her selection of clinical topics presented in the News from the world section. We wish Cristiana all the best in her future activities and, of course, all aspects of life!
I am happy to announce that two new members have joined the Newsletter team. A warm welcome to Elena Tsourdi and Alanna Green! I am sure they will further enrich the Newsletter and that we will all work together in harmony to keep informing ECTS members about various initiatives/activities of ECTS, structure/activities of diverse national bone-related societies, and exciting news from the clinical, translational and basic aspects of bone research.
Elena Tsourdi originally comes from Athens, Greece, and is working as the Senior Consultant at the Department for Metabolic Bone Diseases in at the University Clinic Dresden, Germany, with a focus on secondary osteoporosis and rare bone diseases. Elena studied medicine in Athens; obtained her MD degree at the University Clinic Dresden (TUD) (2011) in the bone field; and finished her residency in Endocrinology (2012) and fellowship in Geriatrics (2022) at the TUD. She actively participates as co-investigator in clinical trials, including the studies of safety and efficacy of romosozumab for the treatment of osteoporosis, the efficacy of bimagrumab to prevent sarcopenia, and the use of recombinant human parathyroid hormone in the treatment of primary hypoparathyroidism. Elena is a devoted member of ECTS, former ECTS Academy Chair and ECTS Board member, and has played important roles in various ECTS-related initiatives and committees. Her smart sense of humor also helps to connect the various aspects of the “North” and “South”!
Alanna Green (aka Leni) is a Research Fellow at The University of Sheffield, where she leads the Cancer and Bone Lab. Her team studies cancer–bone interactions in incurable cancers, such as multiple myeloma. She completed her PhD in 2016 at the St Vincent’s Institute of Medical Research, The University of Melbourne, Australia on retinoid regulation of bone and haematopoiesis. She has since worked on bone regulation of myeloma and development of new cancer therapies. Leni’s group now focuses on developing novel therapeutic strategies for targeting dormant cancer cells to eradicate disease in myeloma and bone metastatic cancers. Leni has been on the Bone Research Society for the past 4 years, and was Lead Organiser of the BRS Basic Course in Bone and Cartilage Biology and Disease 2022. She is a committee member for the National Cancer Research Institute Bone Metastasis Working Group, an Editor for IFMRS HubLE and was elected into ECTS Academy in 2022.